Validity of meta-analysis in diabetes: Meta-analysis is an indispensable tool in evidence synthesis

Diabetes Care

Volumn 36, Issue 10, 2013, Pages 3368-3373

  Golden, Sherita Hill ^a,b   Bass, Eric B ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; PLACEBO; ROSIGLITAZONE;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL DECISION MAKING; CLINICAL RESEARCH; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EDEMA; EVIDENCE BASED PRACTICE; FRACTURE; HEALTH CARE SYSTEM; HEART INFARCTION; HUMAN; INFORMED CONSENT; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE; VALIDATION STUDY; WEIGHT REDUCTION;

DIABETES MELLITUS; HUMANS; META-ANALYSIS AS TOPIC;

EID: 84891880334     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1196     Document Type: Article

References (41)

1. Tonelli MR. The philosophical limits of evidence-based medicine. Acad Med 1998;73:1234-1240
2. Home PD. Validity of meta-analysis in diabetes: We need to be aware of its limitations. Diabetes Care 2013;36:3361-3367
3. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-269, W64
4. Higgin JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration, 2011
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-1900
6. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012
7. Institute of Medicine. Finding What Works in Health Care: Standards for Systematic Reviews. Eden J, Levit L, Berg A, Morton S, Eds. Washington, DC, The National Academies Press, 2011
8. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367
9. Clement S, Braithwaite SS, Magee MF,et al.; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27: 553-591
10. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461
11. Finfer S, Chittock DR, Su SY,et al.; NICESUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297
12. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997;314:1512-1515
13. Malmberg K, Rydén L, Wedel H,et al.; DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005;26:650-661
14. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300: 933-944
15. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011;154:268-282
16. Moghissi ES, Korytkowski MT, DiNardo M,et al.; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32:1119-1131
17. Bennett WL, Bolen S, Wilson LM, Bass EB, Nicholson WK. Performance characteristics of postpartum screening tests for type 2 diabetes mellitus in women with a history of gestational diabetesmellitus: a systematic review. J Womens Health (Larchmt) 2009; 18:979-987
18. Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012;157:336-347
19. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805
20. Singh S, Loke YK, Furberg CD. Longterm risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007; 298:1189-1195
21. Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med 2010;170:1191-1201
22. Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 2009;180:32-39
23. Bennett WL, Maruthur NM, Singh S, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011;154:602-613
24. Nathan DM, Buse JB, Kahn SE,et al.; the GRADE Study Research Group. Rationale and design of the Glycemia Reduction Approaches in diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254-2261
25. Kan C, Silva N, Golden SH, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013;36:480-489
26. Pan A, Keum N, Okereke OI, et al. Bidirectional association between depression and metabolic syndrome: a systematic review andmeta-analysis of epidemiological studies. Diabetes Care 2012;35:1171-1180
27. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008;31:2383-2390
28. Mello MM, Goodman SN, Faden RR. Ethical considerations in studying drug safety-the Institute of Medicine report. N Engl J Med 2012;367:959-964
29. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-1576
30. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-1585
31. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012;367:695-704
32. Golden SH, Brown A, Cauley JA, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an Endocrine Society scientific statement. J Clin Endocrinol Metab 2012; 97:E1579-E1639
33. Admiraal WM, Celik F, Gerdes VE, Dallal RM, Hoekstra JB, Holleman F. Ethnic differences in weight loss and diabetes remission after bariatric surgery: a meta-analysis. Diabetes Care 2012;35:1951-1958
34. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Graham R, Mancher M, and Wolman DM, et al., Eds. Washington, DC, National Academies Press, 2011
35. Bennett WL, Odelola OA, Wilson LM, et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. Ann Intern Med 2012;156:27-36
36. Brito JP, Tsapas A, Griebeler ML, et al. Systematic reviews supporting practice guideline recommendations lack protection against bias. J Clin Epidemiol 2013;66:633-638
37. Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP. Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol 2006;59:697-703
38. OremusM, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord 2001; 12:232-236
39. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-384
40. GRADE Working Group. GRADE guidelines- best practices using the GRADE framework, 2013. Available from http://www.gradeworkinggroup.org/publications/ JCE-series.htm
41. Atkins D, Best D, Briss PA,et al.; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490